FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This First Amendment to Employment Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and Quan Vu (“Executive”) (collectively, the Company and Executive are the “Parties”).
FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This First Amendment to Amended and Restated Employment Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and James N. Woody (“Executive”) (collectively, the Company and Executive are the “Parties”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This First Amendment to Employment Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between Cannbiorex Pharma Ltd., a UK corporation (the “CBR”) and a wholly owned subsidiary of 180 Life Sciences Corp. (“180 LS”, together with CBR, the “Company”), and Marc Feldmann (“Executive”) (collectively, the Company and Executive are the “Parties”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This First Amendment to Employment Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and Jonathan Rothbard (“Executive”) (collectively, the Company and Executive are the “Parties”).
FIRST AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This First Amendment to Consulting Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and Lawrence Steinman (“Executive”) (collectively, the Company and Executive are the “Parties”).
SECOND AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • April 28th, 2022 • 180 Life Sciences Corp. • Pharmaceutical preparations
This Second Amendment to Consulting Agreement (“Amendment”), dated April 27, 2022 and effective as of the same date, unless otherwise set forth below, is entered into by and between Cannbiorex Pharma Ltd., a UK corporation (the “Company”), and Jagdeep Nanchahal (“Consultant”) (collectively, the Company and Consultant are the “Parties”).
